PET biomarker outperforms established risk score in predicting survival for large B-cell lymphoma patients

Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index. By identifying patients who are more likely to have poor outcomes early, the PET biomarker can con